CLIA Currently Waived Analytes

Metadata Updated: November 10, 2020

This database contains the commercially marketed in vitro test systems categorized as CLIA waived by the FDA since January 31, 2000, and by the Centers for Disease Control and Prevention (CDC) prior to that date. CLIA waived test systems are waived from certain CLIA laboratory requirements (42 CFR Part 493).

Access & Use Information

Public: This dataset is intended for public access and use. License: No license information was provided. If this work was prepared by an officer or employee of the United States government as part of that person's official duties it is considered a U.S. Government Work.

Downloads & Resources

Dates

Metadata Created Date November 10, 2020
Metadata Updated Date November 10, 2020

Metadata Source

Harvested from Healthdata.gov

Additional Metadata

Resource Type Dataset
Metadata Created Date November 10, 2020
Metadata Updated Date November 10, 2020
Publisher U.S. Food and Drug Administration
Unique Identifier Unknown
Maintainer
Identifier 3f3f0bb7-1c03-415a-90ca-400bfc08f096
Data First Published 2013-11-01
Data Last Modified 2013-11-01
Public Access Level public
Bureau Code 009:10
Metadata Context https://project-open-data.cio.gov/v1.1/schema/catalog.jsonld
Metadata Catalog ID https://healthdata.gov/data.json
Schema Version https://project-open-data.cio.gov/v1.1/schema
Catalog Describedby https://project-open-data.cio.gov/v1.1/schema/catalog.json
Homepage URL http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfClia/analyteswaived.cfm
Program Code 009:005
Source Datajson Identifier True
Source Hash 38153f8db7c0734fb735ac8e8859369a386d4f34
Source Schema Version 1.1

Didn't find what you're looking for? Suggest a dataset here.